NATIONAL UNIVERSITY CORPORATION OKAYAMA UNIVERSITY;EHIME UNIVERSITY
发明人:
申请号：
EP06811724.1
公开号：
EP1946774B1
申请日:
2006.10.13
申请国别(地区):
EP
年份:
2013
代理人:
摘要：
An objective of the present invention is to provide a suppressant for cerebral infarction occurred after long-term ischemia associated with actual cerebral infarction, and has fewer side effects. The cerebral infarction suppressant of the present invention is characterized in comprising an anti-HMGB1 monoclonal antibody as an active ingredient.
